Antiangiogenic Effects of BCG on Urinary Concentration of Angiogenic Factors
- Status
- TERMINATED
- Phase
- N/A
Clinical Trials Related to Bladder Cancer
Related studies linked through entity extraction aliases.
URO-BCG-4 : Bladder Tumors Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
- Status
- COMPLETED
- Phase
- PHASE1
Phase II Study of Oxaliplatin and Taxotere in Metastatic Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Validation Study of MR Lymphangiography Using SPIO, a New Lymphotropic Superparamagnetic Nanoparticle Contrast
- Status
- TERMINATED
- Phase
- NA
Adjuvant Versus Progression-Triggered Gemcitabine Monotherapy for Locally Advanced Bladder Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
Paclitaxel, Carboplatin and Gemcitabine in the Treatment of Patients With Advanced Transitional Cell Cancer of the Bladder
- Status
- COMPLETED
- Phase
- PHASE2
Cost-Effectiveness in Bladder Cancer
- Status
- UNKNOWN
- Phase
- N/A
Vinflunine in Patients With Locally Advanced or Metastatic Transitional Cell Carcinoma of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2
Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer
- Status
- COMPLETED
- Phase
- N/A
Gemcitabine and Irinotecan in Treating Patients With Locally Advanced or Metastatic Bladder Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Erlotinib and Green Tea Extract (Polyphenon® E) in Preventing Cancer Recurrence in Former Smokers Who Have Undergone Surgery for Bladder Cancer
- Status
- COMPLETED
- Phase
- PHASE2
S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium
- Status
- TERMINATED
- Phase
- PHASE2
Celecoxib and Rosiglitazone in Treating Patients Who Are Undergoing Cystoscopic Surveillance for Early-Stage Noninvasive Carcinoma of the Bladder or Radical Cystectomy for Muscle-Invasive Carcinoma of the Bladder
- Status
- WITHDRAWN
- Phase
- NA
Short-Term Low-Dose Interferon Alfa in Treating Patients With Cancer of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE1
Fluorouracil, Leucovorin, Gemcitabine, and Cisplatin in Treating Patients With Metastatic or Unresectable Adenocarcinoma of the Urothelium or Urachal Remnant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Neoadjuvant Ifosfamide, Doxorubicin, Gemcitabine, and Cisplatin in Treating Patients Who Are Undergoing Radical Cystectomy for Locally Advanced Carcinoma (Cancer) of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2
S0306, Irinotecan in Treating Patients With Recurrent or Refractory Advanced Transitional Cell Cancer of the Urothelium Previously Treated With Chemotherapy
- Status
- COMPLETED
- Phase
- PHASE2
Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter
- Status
- COMPLETED
- Phase
- PHASE2
S0121, Neoadjuvant Carboplatin, Paclitaxel, and Gemcitabine Followed by Cisplatin and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Carcinoma of the Urothelium
- Status
- COMPLETED
- Phase
- PHASE2